Anticancerfund   Report issue

Foundation Phase 3
Founded: Brussels Belgium (2013)

Organization Overview

First Clinical Trial
2018
NCT03464305
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Anticancerfund

Active Ingredients

Drugs in Phase 3 Trials (1)

acetylsalicylic acid (aspirin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colonic Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1